Jagsonpal Pharmaceuticals Limited has informed the Exchange about Schedule of meet
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jagsonpal Pharmaceuticals Limited has informed the stock exchanges about the schedule of an upcoming board meeting. The company has not disclosed the agenda or specific date details in this filing. Typically, such intimation is made under SEBI listing regulations ahead of a board meeting to consider items such as financial results, dividends, fundraising, or other key corporate matters. Retail investors should watch for the follow-up filing that will reveal the outcomes of the meeting.
This is a routine regulatory intimation and, by itself, has no direct impact on the stock price. Investors should wait for the post-meeting outcome filing to understand if any material decision was taken, such as results, dividend, or corporate action.